Emerging Diseases News

Together, a group of viruses nicknamed “FLiRT” have emerged to become the most common SARS-CoV-2 variants in the country.

SAN ANTONIO — We caught up with Connie Steed, MSN, RN, CIC, FAPIC, at the annual meeting of the Association for Professionals in Infection Control and Epidemiology to find out how she got “Hooked on ID.”

We checked in with CDC Director Mandy K. Cohen, MD, MPH, for an update on the agency’s efforts to modernize the nation’s disease surveillance and data systems and improve how the CDC communicates with the public and physicians.

Dermatologists should be on the lookout for new forms of a highly contagious fungal infection now being reported in the U.S., according to a press release from NYU Langone Health.

Moderna announced positive phase 3 trial data for its combination COVID-19 and influenza vaccine this week, suggesting a combination shot for respiratory infections is on the way.

Infants born to mothers vaccinated against COVID-19 during the omicron wave had decreased risks for preterm birth and adverse neonatal outcomes, according to results of the INTERCOVID-2022 study.

More ICU patients with sepsis receiving a continuous vs. intermittent infusion of beta-lactam antibiotics achieved clinical cure by day 14, but 90-day mortality was similar, according to research published in JAMA.

SAN FRANCISCO — COVID-19 infection during pregnancy was associated with increased risk for hypertensive disorders of pregnancy, but not with placental pathology, according to data presented at the ACOG Annual Clinical & Scientific Meeting.

The geographic range of ticks in the United States is expanding, which may place more people than ever at risk for tick-borne diseases. We asked Richard S. Ostfeld, PhD, for an explanation.

Annexon Biosciences has announced positive topline results from a phase 3, randomized placebo-controlled clinical trial examining an investigational monoclonal antibody in those with Guillain-Barré syndrome.